69639-104 : Aloxi .5 mg/.5mg Oral Capsule
| NDC: | 69639-104 |
| Labeler: | Helsinn Therapeutics (U.s.), Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Aloxi |
| Dosage Form: | Oral Capsule |
| Application #: | NDA022233 |
| Rev. Date: |
Appearance:
| Markings: | AIO |
| Shapes: |
Oval |
| Colors: |
 White |
| Size (mm): | 3 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 69639-104-05: 5 CAPSULE IN 1 CARTON (69639‑104‑05) > .5 MG IN 1 CAPSULE
Active Ingredients:
- Palonosetron Hydrochloride
Dosage Strength:
- .5 mg/.5mg
Inactive Ingredients:
- Caprylic/Capric Mono/Di-glycerides
- Glycerin
- Water
- Polyglyceryl-10 Oleate
- Butylated Hydroxyanisole /
Pharmaceutical Classes:
- Serotonin 3 Receptor Antagonists [MoA]
- Serotonin-3 Receptor Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 69639-103 Aloxi .05 mg/ml Intravenous Injection by Helsinn Therapeutics (U.s.), Inc.
- 62856-797 Aloxi .25 mg/5ml Intravenous Injection by Eisai, Inc
- 62856-798 Aloxi .075 mg/1.5ml Intravenous Injection by Eisai, Inc
- 62856-799 Aloxi 0.5 mg (Palonosetron Hydrochloride 0.056 mg) Oral Capsule by Eisai
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69639-103Next: 69639-105 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.